Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Finance and funding news

Show

From To
'Aggressive' pricing helps Merck steal hep C share with newcomer Zepatier

Merck & Co. has yet to report first-quarter earnings, so industry watchers still don’t know exactly how much market share the company’s new hep C combo treatment, Zepatier, has scored since winning approval in late January. But so far, comments from its competitors suggest it’s doing pretty well for itself.

Published
03 May 2016
From
Fierce Pharma
New York Insurers to Change Coverage of Hepatitis C Drugs

Seven health-insurance companies in New York will change their criteria for covering costly drugs that cure chronic hepatitis C under the terms of agreements with the office of State Attorney General Eric Schneiderman.

Published
26 April 2016
From
Wall Street Journal
HIV PrEP currently too pricey to justify use in people who inject drugs

The model suggested that over 20 years, enrolling a quarter of HIV uninfected injection drug users in a PrEP + screening + ART program would be the optimal approach for reducing HIV infection. However, at current drug prices this approach would cost the U.S. an additional $44 billion, which is equivalent to annually spending 10 percent of the current federal budget for domestic HIV/AIDS on PrEP for people who inject drugs.

Published
26 April 2016
From
Medical Xpress
Innovative new programme set to treat 10,000 patients co-infected with hepatitis C and HIV in Africa and Asia

The World Hepatitis Alliance welcomes the announcement of a new programme initiated by the Clinton Health Access Initiative, Inc. (CHAI) and AmeriCares that aims to treat 10,000 co-infected HIV and hepatitis C patients in Africa and Asia with new hepatitis C treatment Daklinza (daclatasvir).

Published
14 April 2016
From
World Hepatitis Alliance
Plan for Poorer Countries to Fund HIV Response Raises Concerns

Calls for low and middle income countries to contribute an additional 6.1 billion dollars to the global HIV response by 2020 could see some vulnerable groups left behind, said HIV activists meeting at the United Nations last week.

Published
12 April 2016
From
Inter Press Service
Dear UNAIDS: Magical thinking on who will fund the AIDS response will not end the epidemic

The agency’s new projections about what is needed to end the AIDS epidemic make completely unrealistic and unreasonable expectations about what low- and middle-income countries can and will pay — suggesting a dangerous donor strategy in the face of high stakes. Low- and middle-income countries can and must pay more — leading AIDS activists from high burden countries have long demanded this and are, in many cases, winning increases. But UNAIDS itself predicts that if the money needed to close this gap does not materialize by 2020, we will not hit the fast track goals.

Published
06 April 2016
From
HealthGAP
India sacks foreign-funded consultants; health programs may suffer

India is firing dozens of foreign-funded health experts working inside the government, seen as part of a broader clampdown to reduce the influence of non-government organizations (NGOs) on policy. Of the nearly 140 people who run India's HIV/AIDS program, 112 are consultants seconded from foreign organizations.

Published
06 April 2016
From
Reuters
Investing in community advocacy and services to end the AIDS epidemic

Greater investment in civil society and community-based service delivery is critical to the Fast-Track approach. Outreach to key populations in low- and middle-income countries should grow to about 7.2% of total investments by 2020, and the estimated resource needs for community-based delivery of antiretroviral therapy should grow to about 3.8% of total investment.

Published
06 April 2016
From
UNAIDS
UNAIDS announces lower price tag on investments needed to Fast-Track ending the AIDS epidemic

Ahead of the United Nations General Assembly High-Level Meeting on Ending AIDS, UNAIDS announced new investment needs to Fast-Track the AIDS response. The projected need of US$ 26.2 billion in 2020 is down from a previous estimate of US$ 30 billion. New findings suggest that the world can reach ambitious Fast-Track targets for preventing new HIV infections, AIDS-related deaths and discrimination with fewer resources.

Published
04 April 2016
From
UNAIDS
NHS England to provide funding for Janssen's HIV treatment, REZOLSTA

Janssen-Cilag Ltd (Janssen) today announced that NHS England (NHSE) will provide crucial funding for its once-daily, fixed-dose combination of darunavir and the pharmacoenhancer, cobicistat, called REZOLSTA® (darunavir/cobicistat).

Published
01 April 2016
From
News-Medical.net
← First12345...87Next →

Filter by country